Dr Lamwaka bags billions in Covid-19 research bonanza

Covid-19 vaccine

AstraZeneca Covid-19 vaccine being administered to frontline personnel in the Tourism and Hospitality sector, at the Kenyatta International Convention Centre on April 27, 2021.

Photo credit:  Jeff Angote | Nation Media Group

What you need to know:

  • The work of innovators like Dr Alice Lamwaka is not an accidental or isolated piece of luck.
  • Rather, it is the fruit of that vision of home-grown and home-growing knowledge that should be the hallmark of an African university.

Lamwaka may very well be the woman of the year (mwaka), just as Lawino is the woman of confidence and beauty. Dr Alice Veronica Lamwaka was this week awarded a Sh3.7 billion research grant to carry out immediate clinical trials for her Covalyce-1 herbal formula, believed to be effective in the management of Covid-19 infections. Dr Lamwaka is the Head of Biotechnology and Pharmaceutical Studies (Pharm-Biotech) at Gulu University, a public institution in the capital of Okot p’Bitek’s Acholi home region.

Welcome!

You're all set to enjoy unlimited Prime content.